MARKET

HELP

HELP

Cybin Inc
NASDAQ
4.510
-0.030
-0.66%
After Hours: 4.560 +0.05 +1.11% 19:56 03/24 EDT
OPEN
4.520
PREV CLOSE
4.540
HIGH
4.580
LOW
4.410
VOLUME
454.43K
TURNOVER
--
52 WEEK HIGH
9.83
52 WEEK LOW
4.410
MARKET CAP
225.66M
P/E (TTM)
-1.2478
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at HELP last week (0316-0320)?
Weekly Report · 1d ago
Cybin Inc. Publishes Corporate Presentation on HLP003 and HLP004 Serotonergic Agonist Programs for MDD and GAD
Reuters · 6d ago
Weekly Report: what happened at HELP last week (0309-0313)?
Weekly Report · 03/16 09:50
Psychedelic: Clearmind advances recruitment for CMND-100 trial’s third cohort
TipRanks · 03/12 14:25
Helus Pharma Adds Chief People Officer as Mental Health Pipeline Advances
TipRanks · 03/12 12:26
Cybin’s Helus Pharma appoints Jill Conwell as Chief People Officer
Reuters · 03/12 11:31
HELUS PHARMA STRENGTHENS EXECUTIVE TEAM WITH APPOINTMENT OF JILL CONWELL AS CHIEF PEOPLE OFFICER
Reuters · 03/12 11:30
Helus Pharma Strengthens Executive Team with Appointment of Jill Conwell as Chief People Officer
Barchart · 03/12 06:30
More
About HELP
Cybin Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company creates psychedelic-based therapeutics to address the unmet need for treatment options for people who suffer from mental health conditions. Its N, N-dimethyltryptamine (DMT) and dDMT programs create a dataset of systematic research on these psychedelic molecules. The Company is developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder, and CYB004, a proprietary deuterated dDMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. CYB003 moves to Phase III and CYB004 moves to Phase II.CYB005 is in Preclinical stage. It has an intellectual property portfolio in the psychedelic drug development sector with over 80 patents granted and over 230 patent applications pending. The Company operates in Canada, the United States, the United Kingdom, the Netherlands, and Ireland.

Webull offers Cybin Inc stock information, including NASDAQ: HELP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HELP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading HELP stock methods without spending real money on the virtual paper trading platform.